These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3491556)

  • 41. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on beta-lactamase in Bacteroides fragilis.
    Nord CE; Dornbusch K; Olsson B
    Infection; 1980; 8 Suppl 2():S167-70. PubMed ID: 6969692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid identification of metallo- and serine beta-lactamases.
    Payne DJ; Cramp R; Bateson JH; Neale J; Knowles D
    Antimicrob Agents Chemother; 1994 May; 38(5):991-6. PubMed ID: 8067782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics].
    Cullmann W; Dick W
    Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.
    Roscoe DL; Zemcov SJ; Thornber D; Wise R; Clarke AM
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2197-200. PubMed ID: 1444299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316.
    Amicosante G; Franceschini N; Segatore B; Oratore A; Fattorini L; Orefici G; Van Beeumen J; Frere JM
    Biochem J; 1990 Nov; 271(3):729-34. PubMed ID: 2123098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F; Keeble J; Williams JD
    Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
    Nagy E; Szóke I; Gacs M; Csiszár K
    Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. beta-lactamase expression in Plesiomonas shigelloides.
    Avison MB; Bennett PM; Walsh TR
    J Antimicrob Chemother; 2000 Jun; 45(6):877-80. PubMed ID: 10837443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Eley A; Greenwood D
    J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
    Lupiola-Gómez PA; González-Lama Z; Tejedor-Junco MT; González-Martín M; Martín-Barrasa JL
    Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent developments in beta-lactamase research and their implications for the future.
    Bush K
    Rev Infect Dis; 1988; 10(4):681-90. PubMed ID: 3055169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Typing by isoelectric focusing of beta-lactamase enzymes in Klebsiella and Enterobacter strains resistant to the new beta-lactam antibiotics].
    Gür D; Akalin HE; Baykal M; Doğrul F
    Mikrobiyol Bul; 1992 Jan; 26(1):1-11. PubMed ID: 1574017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Broad spectrum beta-lactamases of Citrobacter diversus.
    Oliva B; Segatore B; Amicosante G; Franceschini N; Oratore A; Bennett PM
    J Antimicrob Chemother; 1990 Mar; 25(3):335-41. PubMed ID: 2338412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. beta-Lactamase types amongst Staphylococcus aureus isolates in relation to susceptibility to beta-lactamase inhibitor combinations.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):465-81. PubMed ID: 8040112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.